Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction
The importance of the immune system for cardiac repair following myocardial infarction is undeniable; however, the complex nature of immune cell behavior has limited the ability to develop effective therapeutics. This limitation highlights the need for a better understanding of the function of each immune cell population during the inflammatory and resolution phases of cardiac repair. The development of reliable therapies is further complicated by aging, which is associated with a decline in cell and organ function and the onset of cardiovascular and immunological diseases. Aging of the immune system has important consequences on heart function as both chronic cardiac inflammation and an impaired immune response to cardiac injury are observed in older individuals. Several studies have suggested that rejuvenating the aged immune system may be a valid therapeutic candidate to prevent or treat heart disease. Here, we review the basic patterns of immune cell behavior after myocardial infarction and discuss the autonomous and nonautonomous manners of hematopoietic stem cell and immune cell aging. Lastly, we identify prospective therapies that may rejuvenate the aged immune system to improve heart function such as anti-inflammatory and senolytic therapies, bone marrow transplant, niche remodeling and regulation of immune cell differentiation.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Cells - 9(2020), 8 vom: 13. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Tobin, Stephanie W [VerfasserIn] |
---|
Links: |
---|
Themen: |
Aging |
---|
Anmerkungen: |
Date Completed 19.03.2021 Date Revised 19.03.2021 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.3390/cells9081894 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM313973059 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM313973059 | ||
003 | DE-627 | ||
005 | 20231225151728.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cells9081894 |2 doi | |
028 | 5 | 2 | |a pubmed24n1046.xml |
035 | |a (DE-627)NLM313973059 | ||
035 | |a (NLM)32823583 | ||
035 | |a (PII)E1894 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Tobin, Stephanie W |e verfasserin |4 aut | |
245 | 1 | 0 | |a Considering Cause and Effect of Immune Cell Aging on Cardiac Repair after Myocardial Infarction |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.03.2021 | ||
500 | |a Date Revised 19.03.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a The importance of the immune system for cardiac repair following myocardial infarction is undeniable; however, the complex nature of immune cell behavior has limited the ability to develop effective therapeutics. This limitation highlights the need for a better understanding of the function of each immune cell population during the inflammatory and resolution phases of cardiac repair. The development of reliable therapies is further complicated by aging, which is associated with a decline in cell and organ function and the onset of cardiovascular and immunological diseases. Aging of the immune system has important consequences on heart function as both chronic cardiac inflammation and an impaired immune response to cardiac injury are observed in older individuals. Several studies have suggested that rejuvenating the aged immune system may be a valid therapeutic candidate to prevent or treat heart disease. Here, we review the basic patterns of immune cell behavior after myocardial infarction and discuss the autonomous and nonautonomous manners of hematopoietic stem cell and immune cell aging. Lastly, we identify prospective therapies that may rejuvenate the aged immune system to improve heart function such as anti-inflammatory and senolytic therapies, bone marrow transplant, niche remodeling and regulation of immune cell differentiation | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a aging | |
650 | 4 | |a immune system | |
650 | 4 | |a inflammation | |
650 | 4 | |a myocardial infarction | |
650 | 4 | |a therapeutics | |
650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
700 | 1 | |a Alibhai, Faisal J |e verfasserin |4 aut | |
700 | 1 | |a Weisel, Richard D |e verfasserin |4 aut | |
700 | 1 | |a Li, Ren-Ke |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cells |d 2011 |g 9(2020), 8 vom: 13. Aug. |w (DE-627)NLM227066421 |x 2073-4409 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2020 |g number:8 |g day:13 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/cells9081894 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2020 |e 8 |b 13 |c 08 |